Previous Article | Next Article 
Journal of Clinical Microbiology, December 2007, p. 4092-4093, Vol. 45, No. 12
0095-1137/07/$08.00+0 doi:10.1128/JCM.01396-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Designation of Major Mycobacterial Interspersed Repetitive-Unit Types within Mycobacterium tuberculosis Beijing Genotype, an Important Point

LETTER
We read with a great interest the article by Hanekom et al.,
about the
Mycobacterium tuberculosis Beijing genotype in Cape
Town (
1). Colleagues from Stellenbosch University proposed an
intriguing hypothesis in which the population structure of the
clinically relevant lineage within
M. tuberculosis had been
shaped via adaptation to a local human population, whereas all
of the founder strains had a common starting point, having been
imported from East Asia at approximately the same time (
1).
This idea is exciting, although another explanation is that
the disequilibrium of the local population structure, i.e.,
a predominance of the particular variants, may result from the
founder effect due to initially very small imported human/
M. tuberculosis populations (
2,
3). These somewhat contrasting
opinions deserve further testing; both scenarios may be true,
while their interaction could have produced an even stronger
effect.
We noticed, however, one minor but important omission, and we wish to have it corrected. Hanekom et al. (1) compared their mycobacterial interspersed repetitive-unit (MIRU) data from Cape Town with those published for East Asia and concluded that "nine of the Beijing MIRU types (the MT01, MT08, MT11, MT18, MT19, MT21, MT28, MT33, and MT54 types) were shared between these geographical settings (Table 1)." Furthermore, these types are discussed as founder types for the Cape Town population of the M. tuberculosis Beijing genotype (1). Unfortunately, it is not clear from the text or from Table 1 that in fact, all of these types, from MT01 to MT57, were described initially and named in the first global MIRU database of the M. tuberculosis Beijing genotype, compiled and developed in our laboratory in the St. Petersburg Pasteur Institute (3, 4). Its most recent update has just been published (2), and the database may be consulted on request. Our type definition and numbering (3, 4) provided a useful framework for further studies, as the cited article (1) demonstrated. Therefore, our correction to the otherwise valuable publication by Hanekom et al. (1) seems most appropriate.

REFERENCES
1 - Hanekom, M., G. D. van der Spuy, N. C. van Pittius, C. R. McEvoy, S. L. Ndabambi, T. C. Victor, E. G. Hoal, P. D. van Helden, and R. M. Warren. 2007. Evidence that the spread of Mycobacterium tuberculosis strains with the Beijing genotype is human population dependent. J. Clin. Microbiol. 45:2263-2266.[Abstract/Free Full Text]
2 - Mokrousov, I. 2007. Towards a quantitative perception of human-microbial co-evolution. Front. Biosci. 12:4818-4825.[CrossRef][Medline]
3 - Mokrousov, I., H. M. Ly, T. Otten, N. N. Lan, B. Vyshnevskyi, S. Hoffner, and O. Narvskaya. 2005. Origin and primary dispersal of the Mycobacterium tuberculosis Beijing genotype: clues from human phylogeography. Genome Res. 15:1357-1364.[Abstract/Free Full Text]
4 - Mokrousov, I., O. Narvskaya, E. Limeschenko, A. Vyazovaya, T. Otten, and B. Vyshnevskiy. 2004. Analysis of the allelic diversity of the mycobacterial interspersed repetitive units in Mycobacterium tuberculosis strains of the Beijing family: practical implications and evolutionary considerations. J. Clin. Microbiol. 42:2438-2444.[Abstract/Free Full Text]
| | | | | |
Igor Mokrousov*
Olga Narvskaya
Laboratory of Molecular Microbiology St. Petersburg Pasteur Institute 14 Mira Street St. Petersburg 197101 Russia
|
| | | | | |
* Phone: 7 812 233 21 49, Fax: 7 812 232 92 17, E-mail: igormokrousov{at}yahoo.com |
Authors' Reply

LETTER
In two recent publications (
1,
2), we reported using molecular
epidemiological approaches to investigate the population structure
of
M. tuberculosis strains with the Beijing genotype in South
Africa, and these data were compared to previously published
data on the population structure of strains with the Beijing
genotype in East Asia. We showed that strains within sublineage
7 were overrepresented in South Africa compared to those in
East Asia (
2). Accordingly, we hypothesized that either strains
from sublineage 7 had evolved a higher level of fitness since
their arrival in South Africa or that the host genetics of the
South African population was different from that in East Asia
and thereby was less likely to prevent disease progression with
strains from this lineage (
2). Mokrousov and Narvskaya have
put forward an alternative explanation. It is suggested that
the overrepresentation of sublineage 7 strains may have resulted
from disequilibrium of the local population structure, i.e.,
the introduction of the sublineage 7 founder strain into a small
human population. In this scenario, the sublineage 7 strain
would have spread into the small population, amplifying the
number of "founder" cases. The numerical advantage gained in
this manner would imply that sublineage 7 strains would always
be overrepresented in this population if founder strains from
the other sublineages (1 to 6) were introduced only subsequently.
This would imply that all strains with the Beijing genotype
(irrespective of sublineage) would be equally fit. Although
we acknowledge that this scenario could have occurred, we suggest
that the statistical probability would be small, given that
the sublineage 7 strains are underrepresented in East Asia,
and therefore it would have been more likely that a strain from
sublineages 1 to 6 was initially introduced into South Africa.
Our suggestion is supported by the observation that founder
strains from sublineages 1 to 6 were overrepresented in the
South African study setting (
2). Our hypothesis that sublineage
7 strains show a higher level of fitness in the South African
population is supported by the observation that sublineage 7
strains show a higher propensity to transmit than strains from
sublineages 1 to 6 (
1). Molecular epidemiological studies also
support the notion that the more recently evolved strains (termed
typical Beijing strains) are adapted to spread and cause disease,
given their frequency of occurrence, in comparison to distantly
evolved strains (termed atypical Beijing strains) (
3,
4).
Concerning the naming of the MT types, we acknowledge the St. Petersburg Pasteur Institute's role in initially describing these MIRU types.

REFERENCES
1 - Hanekom, M., G. D. van der Spuy, E. Streicher, S. L. Ndabambi, C. R. McEvoy, M. Kidd, N. Beyers, T. C. Victor, P. D. van Helden, and R. M. Warren. 2007. A recently evolved sublineage of the Mycobacterium tuberculosis Beijing strain family was associated with an increased ability to spread and cause disease. J. Clin. Microbiol. 45:1483-1490.[Abstract/Free Full Text]
2 - Hanekom, M., G. D. van der Spuy, N. C. van Pittius, C. R. McEvoy, S. L. Ndabambi, T. C. Victor, E. G. Hoal, P. D. van Helden, and R. M. Warren. 2007. Evidence that the spread of Mycobacterium tuberculosis strains with the Beijing genotype is human population dependent. J. Clin. Microbiol. 45:2263-2266.[Abstract/Free Full Text]
3 - Mokrousov, I., O. Narvskaya, T. Otten, A. Vyazovaya, E. Limeschenko, L. Steklova, and B. Vyshnevskyi. 2002. Phylogenetic reconstruction within Mycobacterium tuberculosis Beijing genotype in northwestern Russia. Res. Microbiol. 153:629-637.[Medline]
4 - Toungoussova, O. S., P. Sandven, A. O. Mariandyshev, N. I. Nizovtseva, G. Bjune, and D. A. Caugant. 2002. Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia. J. Clin. Microbiol. 40:1930-1937.[Abstract/Free Full Text]
| | | | | |
M. Hanekom
G. D. van der Spuy
N. C. Gey van Pittius
C. R. E. McEvoy
S. L. Ndabambi
T. C. Victor
E. G. Hoal
P. D. van Helden
R. M. Warren*
DST/NRF Centre of Excellence for Biomedical Tuberculosis Research MRC Centre for Molecular and Cellular Biology Division of Molecular Biology and Human Genetics Faculty of Health Sciences Stellenbosch University P.O. Box 19063 Tygerberg 7505 South Africa
|
| | | | | |
* Phone: 021 938 9073 Fax: 021 938 9476 E-mail: rw1{at}sun.ac.za |
Journal of Clinical Microbiology, December 2007, p. 4092-4093, Vol. 45, No. 12
0095-1137/07/$08.00+0 doi:10.1128/JCM.01396-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.